Cancer

RSS

ISIS-3521/CGP-64128A efficacy shown in preclinical models

Aug. 16, 1996

MAM-102: antineoplastic protein tyrosine kinase inhibitor

Aug. 16, 1996

Letrozole approved for marketing in France

Aug. 16, 1996

Sanofi Winthrop discloses topoisomerase II inhibitors

Aug. 16, 1996

Guilford to develop anticancer drugs in biodegradable polymers

Aug. 16, 1996

SuperGen acquires marketing rights for Barr generic drugs

Aug. 16, 1996

SS Pharm. discloses antitumor platinum complexes

Aug. 16, 1996

NCI supports clinical testing of MGI-114

Aug. 16, 1996

NCI begins pediatric study of carboplatin/RMP-7 combination

Aug. 16, 1996

FDA approves new formulation of Gensi Laboratories' etoposide

Aug. 9, 1996